Although it is estimated that COVID-19 life-threatening conditions may be diagnosed in less
than 1: 1000 infected individuals below the age of 50, but the real impact of this pandemic …

Introduction Patients with immunodeficiency are usually more prone to worse outcomes of
infectious diseases. However, there are some disagreements in the context of COVID-19, for …

Method We retrospectively analyzed PID patients in our center, Hacettepe University,
Department of Pediatric Immunology, who had SARS-CoV2 PCR positivity in …

A better understanding of COVID-19 in people with primary immunodeficiency (PI), rare
inherited defects in the immune system, is important for protecting this population, especially …

In the last few months the world has witnessed a global pandemic due to severe acute
respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection causing coronavirus disease …

The novel coronavirus disease 19 (COVID-19) is an acute infectious respiratory disorder that
emerged from Wuhan, China in the late 2019. 1, 2 Due to its rapid distribution, the disease …

COVID-19 has had a calamitous effect on the global community. Despite intense study, the
immunologic response to the infection is only partially understood. In addition to older age …

Objectives SARS-CoV-2 infection has now a global resonance. Data on how COVID-19 is
affecting immunocompromised patients are however few. With our study we aimed to …

Background As of November 2020, severe acute respiratory syndrome coronavirus 2 has
resulted in 55 million infections worldwide and more than 1.3 million deaths from …

Background: The role of humoral immunity has been well established in reducing infection
risk and facilitating viral clearance in patients with COVID-19. However, the relationship …